Brian Kotzin

Brian L.
Kotzin is currently an Independent Director at Rigel Pharmaceuticals, Inc., a Director at Benaroya Research Institute at Virginia Mason, an Independent Director at Biora Therapeutics, Inc., an Independent Director at Kyverna Therapeutics, Inc., a Director at Genascence Corp., a Non-Executive Director at argenx SE, a Member of the Association of American Physicians, and a Member of the American Society of Clinical Investigation.
Previously, Dr. Kotzin held positions as the Chairman-Immunological Sciences Study Section at the National Institutes of Health, the Director-Autoimmunity Centre of Excellence at the University of Colorado Health Sciences Center, a Director at the American College of Rheumatology, a Director at the Federation of Clinical Immunology Societies, and a Director at Vera Therapeutics, Inc. He also served as the Director & Head-Clinical Immunology at the Autoimmunity Center of Excellence from 1998 to 2004, the VP-Global Clinical Development & Head-Inflammation at Amgen, Inc. from 2004 to 2015, and the Chief Medical Officer & Senior Vice President at Nektar Therapeutics from 2017 to 2023.
Additionally, he was the Chief-Rheumatology Section at the Veterans Administration Medical Center and a Professor at National Jewish Health, Inc.Dr. Kotzin completed his undergraduate studies at the University of Southern California and obtained his doctorate from Stanford University School of Medicine.